Overview

Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of Duloxetine in the treatment of obsessive compulsive disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride